(Q48492445)

12 February 2018

title

Amyloid-β protein modulates insulin signaling in presynaptic terminals (English)

1 reference

12 February 2018

1 reference

David Heras-Sandoval

1

1 reference

12 February 2018

Patricia Ferrera

series ordinal

2

1 reference

12 February 2018

Clorinda Arias

series ordinal

3

1 reference

12 February 2018

publication date

26 May 2012

1 reference

12 February 2018

published in

Neurochemical Research

1 reference

12 February 2018

volume

37

1 reference

12 February 2018

issue

9

1 reference

12 February 2018

page(s)

1879-1885

1 reference

12 February 2018

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Structural correlates of cognition in dementia: quantification and assessment of synapse change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Synaptic slaughter in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

beta-Amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Distribution of insulin receptor-like immunoreactivity in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Cardiovascular risk factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Improving influence of insulin on cognitive functions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Ageing and diabetes: implications for brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Improved method for isolating synaptosomes from 11 regions of one rat brain: electron microscopic and biochemical characterization and use in the study of drug effects on nerve terminal gamma-aminobutyric acid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase- dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Insulin-like growth factor 1 regulates developing brain glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

The nuts and bolts of AGC protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0800-7

Amyloid beta oligomers induce impairment of neuronal insulin receptors

21 January 2018

1 reference

12 December 2020

Mechanism of activation of protein kinase B by insulin and IGF-1

1 reference

12 December 2020

Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders

1 reference

12 December 2020

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

1 reference

12 December 2020

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine

1 reference

12 December 2020

The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses

1 reference

12 December 2020

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor

1 reference

12 December 2020

10.1007/S11064-012-0800-7

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018